Business Context and Reporting Period
This Form 8-K is a Current Report filed by Ra Medical Systems, Inc. (not Catheter Precision, Inc., which is the target of a pending merger) on October 28, 2022. The filing reports the termination of a material definitive agreement (a lease) and provides updates regarding a pending reverse merger with Catheter Precision, Inc.
Key Financial Metrics and Material Changes
This filing does not contain standard periodic financial statements (revenue, profit, or cash flow) for Ra Medical Systems, Inc. However, it discloses specific financial impacts related to the lease termination:
- Termination Fee: Ra Medical agreed to pay a $300,000 fee to the landlord (Anaya Holdings LLC).
- Security Deposit Forfeiture: The Company released its right to a $36,017.14 security deposit previously held by the landlord.
- Strategic Rationale: The lease termination was executed to minimize cash burn in anticipation of the pending merger with Catheter Precision, Inc.
Note: Detailed revenue, margin, and liquidity metrics for Ra Medical or Catheter Precision are not provided in this specific document but are referenced as available in prior filings (e.g., Form 10-Q for the period ended June 30, 2022, and the September 12, 2022 Form 8-K).
Guidance, Outlook, and Management Commentary
Pending Merger: Ra Medical is in the process of a stock-for-stock reverse merger with Catheter Precision, Inc., a private medical device company focused on cardiac electrophysiology. The transaction is expected to close before the end of 2022, subject to shareholder approval and other closing conditions.
Forward-Looking Statements: Management notes that the combined company will focus on the cardiac electrophysiology market. However, the filing includes significant cautionary language regarding:
- The ability to consummate the merger and satisfy closing conditions.
- Requirements for a minimum prevailing stock price and a specific Net Cash amount at closing.
- Potential adverse impacts on merger consideration if Ra Medical's stock price drops below certain levels.
- Risks related to the "shell company" rules and the ability to maintain a listing on the NYSE American.
Investor Verification Checklist
- Verify the status of the Definitive Proxy Statement and the Private Placement Memorandum/Joint Information Statement for details on the merger terms and voting procedures.
- Review the September 12, 2022 Form 8-K for the audited and unaudited financial statements of Catheter Precision, Inc., as referenced in this filing.
- Confirm the current Net Cash position of Ra Medical to ensure it meets the closing conditions of the Merger Agreement.
- Monitor Ra Medical's stock price relative to the minimum prevailing stock price condition required for the merger to close.
- Check for any updates on the shareholder approval process for both Ra Medical and Catheter Precision.